Drug
ZL 2306
ZL 2306: highest development phase Phase 3, developed by Zai Lab. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Zai Lab
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZL-2306 (Nirapairb) NCT03709316 | Phase 3 | Ovarian Cancer |
| ZL-2306(nirapairb) NCT03705156 | Phase 3 | Platinum-sensitive Relapsed Ovarian Cancer |
Latest
No recent events.
Follow ZL 2306 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.